Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection ; volume:14 ; number:1 ; day:9 ; month:9 ; year:2024 ; pages:1-8 ; date:12.2024
Scientific reports ; 14, Heft 1 (9.9.2024), 1-8, 12.2024
- Urheber
-
Li, Xiaodan
Song, Dongxu
Hao, Yingxuan
Ren, Mingjing
Guo, Yanhong
Zhao, Huayan
Wang, Yulin
Tang, Lin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-72082-y
- URN
-
urn:nbn:de:101:1-2411232111487.322071956586
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Xiaodan
- Song, Dongxu
- Hao, Yingxuan
- Ren, Mingjing
- Guo, Yanhong
- Zhao, Huayan
- Wang, Yulin
- Tang, Lin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Perspectives in membranous nephropathy
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Antigen-specific therapies of membranous nephropathy
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
Advances in Pathogenesis of Idiopathic Membranous Nephropathy
Horseshoe kidney with PLA2R-positive membranous nephropathy
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Perspectives in membranous nephropathy
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Antigen-specific therapies of membranous nephropathy
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
Advances in Pathogenesis of Idiopathic Membranous Nephropathy
Horseshoe kidney with PLA2R-positive membranous nephropathy
Rituximab may affect T lymphocyte subsets balance in primary membranous nephropathy
Lupus Membranous Nephropathy
Perspectives in membranous nephropathy
Rituximab Treatment in a Patient with Kimura Disease and Membranous Nephropathy: Case Report
Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach
C4d immunohistochemistry in membranous nephropathy
Treatment of Membranous Nephropathy in Chinese Patients: Comparison of Rituximab and Intravenous Cyclophosphamide with Steroids
Membranous nephropathy: a retrospective observational study of membranous nephropathy in north east and central London
Antigen-specific therapies of membranous nephropathy
Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series
Advances in Pathogenesis of Idiopathic Membranous Nephropathy